KR100234863B1 - 사람 면역결핍 바이러스 프로테아제 억제제 - Google Patents
사람 면역결핍 바이러스 프로테아제 억제제 Download PDFInfo
- Publication number
- KR100234863B1 KR100234863B1 KR1019960703165A KR19960703165A KR100234863B1 KR 100234863 B1 KR100234863 B1 KR 100234863B1 KR 1019960703165 A KR1019960703165 A KR 1019960703165A KR 19960703165 A KR19960703165 A KR 19960703165A KR 100234863 B1 KR100234863 B1 KR 100234863B1
- Authority
- KR
- South Korea
- Prior art keywords
- hiv
- compound
- treatment
- infection
- aids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16801393A | 1993-12-15 | 1993-12-15 | |
| US8/168013 | 1993-12-15 | ||
| US17047593A | 1993-12-20 | 1993-12-20 | |
| US8/170475 | 1993-12-20 | ||
| PCT/US1994/014187 WO1995016688A1 (en) | 1993-12-15 | 1994-12-12 | Hiv protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR100234863B1 true KR100234863B1 (ko) | 1999-12-15 |
Family
ID=26863718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019960703165A KR100234863B1 (ko) | 1993-12-15 | 1994-12-12 | 사람 면역결핍 바이러스 프로테아제 억제제 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5646148A (pt) |
| EP (1) | EP0734387B1 (pt) |
| JP (1) | JP3000564B2 (pt) |
| KR (1) | KR100234863B1 (pt) |
| CN (1) | CN1046727C (pt) |
| AT (1) | ATE215952T1 (pt) |
| AU (1) | AU692509B2 (pt) |
| BG (1) | BG62093B1 (pt) |
| BR (1) | BR9408305A (pt) |
| CA (1) | CA2178760C (pt) |
| CZ (1) | CZ288312B6 (pt) |
| DE (1) | DE69430385T2 (pt) |
| ES (1) | ES2174921T3 (pt) |
| FI (1) | FI962488A (pt) |
| HU (1) | HUT74681A (pt) |
| NZ (1) | NZ278201A (pt) |
| PL (1) | PL314984A1 (pt) |
| SK (1) | SK75796A3 (pt) |
| WO (1) | WO1995016688A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997017981A1 (en) | 1995-11-13 | 1997-05-22 | Gerard Voerman | Anti-viral isolates obtainable from leeches |
| MY126358A (en) * | 1996-03-22 | 2006-09-29 | Glaxo Group Ltd | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs |
| TW438799B (en) * | 1997-05-29 | 2001-06-07 | Merck & Co Inc | HIV protease inhibitor |
| ZA984514B (en) * | 1997-05-29 | 1998-11-30 | Merck & Co Inc | Hiv protease inhibitor |
| US6180634B1 (en) | 1997-11-13 | 2001-01-30 | Merck & Co., Inc. | Combination therapy for the treatment of AIDS |
| CO4970782A1 (es) * | 1997-11-13 | 2000-11-07 | Merck & Co Inc | Terapia combinada para el tratamiento del sida |
| US6251906B1 (en) | 1998-05-15 | 2001-06-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| FR2780649B1 (fr) * | 1998-07-06 | 2001-03-09 | Univ Paris Vii Denis Diderot | Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine |
| GB2341385A (en) | 1998-09-14 | 2000-03-15 | Merck & Co Inc | Recovery of iodide from chemical process waste water |
| US6440946B1 (en) * | 1999-02-25 | 2002-08-27 | Takeda Chemical Industries, Ltd. | Multiple-agents-binding compound, production and use thereof |
| US6589962B1 (en) | 1999-07-20 | 2003-07-08 | Merck & Co., Inc. | Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| WO2001038332A1 (en) * | 1999-11-24 | 2001-05-31 | Merck & Co., Inc. | Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| US6482952B2 (en) | 2000-06-20 | 2002-11-19 | Merck & Co., Inc. | Process for preparing acetonides |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| WO2004027361A1 (en) * | 2002-09-17 | 2004-04-01 | University Of Virginia Patent Foundation | Remote temperature sensing of small volume and related apparatus thereof |
| GB0720503D0 (en) * | 2007-10-22 | 2007-11-28 | Angeletti P Ist Richerche Bio | New compound |
| US20130115237A1 (en) | 2010-06-09 | 2013-05-09 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
| CN108178764A (zh) * | 2018-01-09 | 2018-06-19 | 天津科技大学 | 呋喃并[2,3-b]吡啶类化合物及无金属催化的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
| WO1993008184A1 (en) * | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Hiv protease inhibitors |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| CA2195027C (en) * | 1991-11-08 | 2000-01-11 | Joseph P. Vacca | Hiv protease inhibitors useful for the treatment of aids |
| RU2139052C1 (ru) * | 1993-03-31 | 1999-10-10 | Мерк Энд Ко., Инк. | Комбинация ингибитора вич-протеазы с другими антивирусными соединениями, фармацевтическая композиция на их основе и способ получения фармацевтической композиции |
-
1994
- 1994-12-12 WO PCT/US1994/014187 patent/WO1995016688A1/en active Search and Examination
- 1994-12-12 JP JP7516855A patent/JP3000564B2/ja not_active Expired - Fee Related
- 1994-12-12 BR BR9408305A patent/BR9408305A/pt not_active Application Discontinuation
- 1994-12-12 AU AU14331/95A patent/AU692509B2/en not_active Ceased
- 1994-12-12 SK SK757-96A patent/SK75796A3/sk unknown
- 1994-12-12 NZ NZ278201A patent/NZ278201A/en unknown
- 1994-12-12 EP EP95905886A patent/EP0734387B1/en not_active Expired - Lifetime
- 1994-12-12 KR KR1019960703165A patent/KR100234863B1/ko not_active IP Right Cessation
- 1994-12-12 DE DE69430385T patent/DE69430385T2/de not_active Expired - Fee Related
- 1994-12-12 ES ES95905886T patent/ES2174921T3/es not_active Expired - Lifetime
- 1994-12-12 PL PL94314984A patent/PL314984A1/xx unknown
- 1994-12-12 HU HU9601649A patent/HUT74681A/hu unknown
- 1994-12-12 AT AT95905886T patent/ATE215952T1/de not_active IP Right Cessation
- 1994-12-12 CN CN94194954A patent/CN1046727C/zh not_active Expired - Fee Related
- 1994-12-12 CZ CZ19961586A patent/CZ288312B6/cs not_active IP Right Cessation
- 1994-12-12 CA CA002178760A patent/CA2178760C/en not_active Expired - Fee Related
-
1995
- 1995-03-29 US US08/412,509 patent/US5646148A/en not_active Expired - Fee Related
-
1996
- 1996-06-05 BG BG100643A patent/BG62093B1/bg unknown
- 1996-06-14 FI FI962488A patent/FI962488A/fi unknown
-
1997
- 1997-04-08 US US08/825,787 patent/US5807841A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUT74681A (en) | 1997-01-28 |
| EP0734387A4 (en) | 1997-03-05 |
| DE69430385T2 (de) | 2002-11-07 |
| WO1995016688A1 (en) | 1995-06-22 |
| ES2174921T3 (es) | 2002-11-16 |
| CZ288312B6 (en) | 2001-05-16 |
| AU692509B2 (en) | 1998-06-11 |
| CA2178760A1 (en) | 1995-06-22 |
| BR9408305A (pt) | 1997-08-26 |
| BG62093B1 (bg) | 1999-02-26 |
| ATE215952T1 (de) | 2002-04-15 |
| FI962488A0 (fi) | 1996-06-14 |
| CN1046727C (zh) | 1999-11-24 |
| CA2178760C (en) | 2000-08-01 |
| NZ278201A (en) | 1998-01-26 |
| CN1142827A (zh) | 1997-02-12 |
| EP0734387B1 (en) | 2002-04-10 |
| HU9601649D0 (en) | 1996-08-28 |
| AU1433195A (en) | 1995-07-03 |
| US5807841A (en) | 1998-09-15 |
| SK75796A3 (en) | 1997-05-07 |
| EP0734387A1 (en) | 1996-10-02 |
| CZ158696A3 (en) | 1996-11-13 |
| DE69430385D1 (de) | 2002-05-16 |
| PL314984A1 (en) | 1996-09-30 |
| BG100643A (bg) | 1997-02-28 |
| US5646148A (en) | 1997-07-08 |
| JP3000564B2 (ja) | 2000-01-17 |
| JPH09506619A (ja) | 1997-06-30 |
| FI962488A (fi) | 1996-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100234863B1 (ko) | 사람 면역결핍 바이러스 프로테아제 억제제 | |
| EP0541168B1 (en) | HIV protease inhibitors useful for the treatment of aids | |
| JP4982482B2 (ja) | Ｈｉｖインテグラ−ゼ阻害剤 | |
| SK136395A3 (en) | Hiv protease inhibitors and pharmaceutical composition containing them | |
| CN113286794A (zh) | Kras突变蛋白抑制剂 | |
| JP2003514910A (ja) | Ｈｉｖプロテアーゼ阻害剤としてのガンマ−ヒドロキシ−２−（フルオロアルキルアミノカルボニル）−１−ピペラジンペンタンアミド類 | |
| CZ252895A3 (en) | COMBINATION OF N-(2(R)-HYDROXY-1(S)-INDANYL)-2(R)-PHENYLMETHYL-4(S)-HYDROXY-R-(1-(4- (3-PYRIDYLMETHYL)-2(S)-N°-(TERT-BUTYLCARBAMOYL)PIPERAZINYL)PENTANAMIDE WITH AZT, ddI, OR ddC, PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMBINATION AND THE USE OF THE COMBINATION FOR PREPARING THE PHARMACEUTICAL PREPARATION | |
| JP2012528160A (ja) | Ｈｉｖプロテアーゼ阻害薬 | |
| US20030119848A1 (en) | Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient | |
| JP2817907B2 (ja) | 抗菌剤製造用の中間体 | |
| UA45317C2 (uk) | Спосіб одержання інгібіторів віл-протеази, проміжні сполуки та спосіб їх отримання | |
| JP2003171381A (ja) | エントリー阻害剤 | |
| NO323263B1 (no) | Heterosyklisk derivat, fremgangsmater for dets fremstilling, farmasoytiske sammensetninger som inneholder dette, anvendelse av dette for fremstilling av et preparat for medisinsk bruk samt nevnte derivat til bruk som medikament | |
| KR100375112B1 (ko) | 퀴녹살린디온 | |
| RU2137768C1 (ru) | Ингибиторы hiv протеазы | |
| RU2171254C2 (ru) | Способ получения производных пиперазинилпентанамида и производное пиперазинилпентанамида | |
| TW202214585A (zh) | 經取代之異喹啉基甲基醯胺類、其類似物及使用其之方法 | |
| WO1996001260A1 (fr) | Derive d'acide pyridone-carboxylique, l'un de ses esters, l'un de ses sels, et produit intermediaire pour la synthese de ces composes | |
| CZ335595A3 (en) | N-substituted azaheterocyclic carboxylic acids and their esters, process of their preparation and pharmaceutical compositions containing thereof | |
| JP2003504383A (ja) | アルファ−ヒドロキシ−ガンマ−［［（炭素環式−又はヘテロ環式−置換）アミノ］カルボニル］アルカンアミド誘導体及びこれらの使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |